Stephen E Wang
Overview
Explore the profile of Stephen E Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kopetz S, Guthrie K, Morris V, Lenz H, Magliocco A, Maru D, et al.
J Clin Oncol
. 2020 Dec;
39(4):285-294.
PMID: 33356422
Purpose: mutations are rarely associated with objective responses to the BRAF inhibitor vemurafenib in patients with metastatic colorectal cancer (CRC). Blockade of by vemurafenib causes feedback upregulation of EGFR, whose...
2.
Boland J, Shahbazi D, Wang S, Shahbazi S
Perm J
. 2020 Feb;
24.
PMID: 32069206
Introduction: Hypercalcemia is a common phenomenon in patients with cancer but is more common among certain cancer types. Hypercalcemia in ovarian cancer is the common presenting sign in small cell...
3.
Wild C, Wang S, Gandara D, Lara Jr P, Meyers F, Tanaka Jr M, et al.
Oncology (Williston Park)
. 2003 Jul;
17(7 Suppl 7):11-6.
PMID: 12886868
A novel schema of intrapatient dose escalation was applied to determine a population-based maximum tolerated dose (pMTD) for irinotecan (CPT-11, Camptosar) and carboplatin (Paraplatin) in a phase I trial. A...
4.
Wang S, Lara Jr P, Reed J, Wang L, Palmer P, Tuscano J, et al.
Am J Hematol
. 2002 Jul;
70(3):191-4.
PMID: 12111764
Non-hemolytic transfusion reactions (NHTR) occur in up to 30% of patients receiving platelet transfusions. Premedication with acetaminophen and diphenhydramine is a common strategy to prevent NHTR, but its efficacy has...